Showing results (1131-1140 of 9,978) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|February 15, 2021
A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndromeGail J Roboz, Pinkal Desai, Sangmin Lee, et al.Leukemia & Lymphoma|February 15, 2021
Non-EBV infection-associated hemophagocytic lymphohistiocytosis: a distinct subgroup where pathogen-directed therapy is essential and favorable outcomes are expectedYahong You, Jingshi Wang, Yini Wang, et al.Leukemia & Lymphoma|February 11, 2021
Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration SystemChristopher R Frei, Hannah Le, Daniel McHugh, et al.Leukemia & Lymphoma|January 21, 2017
A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphomaBeata Holkova, Victor Yazbeck, Maciej Kmieciak, et al.Leukemia & Lymphoma|August 8, 2019
Costs associated with follicular lymphoma among individuals diagnosed with non-Hodgkin lymphoma: a longitudinal analysis using SEER-Medicare dataHusam Albarmawi, Madhuram Nagarajan, Kai Sun, et al.Leukemia & Lymphoma|September 5, 2019
Asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly-diagnosed acute lymphoblastic leukemiaClaudia Lanvers-Kaminsky, Andreas Niemann, Maria Eveslage, et al.Leukemia & Lymphoma|September 27, 2019
Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?Mattia Novo, Grzegorz S Nowakowski, Thomas M Habermann, et al.Leukemia & Lymphoma|September 27, 2019
Posterior reversible encephalopathy syndrome in pediatric patients: pathophysiology, diagnosis, and managementMichael G Z Ghali, Justin Davanzo, Madeline Leo, et al.Leukemia & Lymphoma|September 14, 2019
Long-term outcomes of patients treated with an EPOCHL regimen as first-line chemotherapy for newly diagnosed extranodal natural killer/T-cell lymphoma: a retrospective single-center studyLiqiang Wei, Jingwen Wang, Jin Ye, et al.Leukemia & Lymphoma|September 19, 2019
Levocarnitine does not impair chemotherapy cytotoxicity against acute lymphoblastic leukemiaJessica L Sea, Etan Orgel, Ting Chen, et al.Pageof 998